targetex logo

NEWS

TargetEx moved to a new location.

The optimized layout of the new location allows us to work even more efficiently.

TargetEx Ltd has moved from its former location at 29 Karolina út to the Bay INNO Innovation Park at 132-144 Fehérvári út. This was the first time the company has changed its locatin in 19 years.

In connection with the change of location, we have considered in detail the most efficient way of carrying out the individual work processes and paid special attention to the optimal equipment of the laboratories. The new location offers a sterile lab, expression lab, FPLC separation labs, preparation rooms, spacious offices and ample storage facilities to support the work of our excellent researchers.

The spatial arrangement and spacing of the equipment allows for the fastest and most comfortable working environment, with impeccable cleanliness and orderly operation.

‘We have considered in detail the most efficient way of carrying out the individual work processes and paid special attention to the optimal equipment of the laboratories.’

The building itself is home to researchers in fields such as artificial intelligence-based systems engineering, food analytics, environmental microbiology, industrial laser technology, etc. As a protein biotechnology company, we fit perfectly into the facilities profile and our excellent relationship with our neighbours allows us to further expand our own professional toolbox.

It is a great pleasure for all our employees that we can continue our innovative work in the new location, in the heart of Buda, in an optimal environment and with the possibility to expand our partnerships. One of the cornerstones of our many ambitious goals is the new location, which we already consider our home and welcome our guests and partners.

More news mentions & press releases

Our reliability is guaranteed for the future

Once again we have successfully passed the renewal ISO audit

RibonEx, the first off-the-shelf TargetEx product, is now available to everyone

We have launched our first finished product, the RNase inhibitor RibonEx.

TargetEx receives great honor

We won the Innovation Prize for the development of our protein expression and protein purification platform.